Management of gallstones and gallbladder disease in patients undergoing gastric bypass

World Journal of Gastroenterology

Volumn 16, Issue 17, 2010, Pages 2075-2079

  Quesada, Bernabé M ^a   Kohan, Gustavo ^a   Roff, Hernán E ^a   Canullán, Carlos M ^a   Chiappetta Porras, Luis T ^a  

^a HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

Author keywords

Cholecystectomy; Gallbladder; Gallstones; Gastric bypass; Morbid obesity

Indexed keywords

IBUPROFEN; PLACEBO; URSODEOXYCHOLIC ACID;

CHOLECYSTECTOMY; CLINICAL TRIAL; EDITORIAL; GALLBLADDER DISEASE; GALLSTONE; HUMAN; INCIDENCE; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MORBID OBESITY; MORBIDITY; OPERATION DURATION; STOMACH BYPASS; SURGICAL APPROACH; TREATMENT INDICATION;

EID: 77952492401     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i17.2075     Document Type: Editorial

References (65)

1. Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, Pitt HA. Gallstones: genetics versus environment. Ann Surg 2002; 235: 842-849
2. Sarin SK, Negi VS, Dewan R, Sasan S, Saraya A. High familial prevalence of gallstones in the first-degree relatives of gallstone patients. Hepatology 1995; 22: 138-141
3. Dittrick GW, Thompson JS, Campos D, Bremers D, Sudan D. Gallbladder pathology in morbid obesity. Obes Surg 2005; 15: 238-242
4. Erlinger S. Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol 2000; 12: 1347-1352
5. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989; 149: 1750-1753
6. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652-658
7. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117: 632-639
8. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321: 563-569
9. Pauletzki J, Paumgartner G. Review article: defects in gall-bladder motor function--role in gallstone formation and recurrence. Aliment Pharmacol Ther 2000; 14 Suppl 2: 32-34
10. Weinsier RL, Ullmann DO. Gallstone formation and weight loss. Obes Res 1993; 1: 51-56
11. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993; 119: 1029-1035
12. Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, Romano F, Roda E. Review: low caloric intake and gall-bladder motor function. Aliment Pharmacol Ther 2000; 14 Suppl 2: 51-53
13. Kamrath RO, Plummer LJ, Sadur CN, Adler MA, Strader WJ, Young RL, Weinstein RL. Cholelithiasis in patients treated with a very-low-calorie diet. Am J Clin Nutr 1992; 56: 255S-257S
14. Yang HY, Peterson GM, Mraks JW, Roth MP, Schoenfield LJ. Risk factors for gallstone formation during rapid weight loss (Abstract). Gastroenterology 1990; 98: A266
15. Gebhard RL, Prigge WF, Ansel HJ, Schlasner L, Ketover SR, Sande D, Holtmeier K, Peterson FJ. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 1996; 24: 544-548
16. Shiffman ML, Sugerman HJ, Kellum JM, Moore EW. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology 1992; 103: 214-221
17. Petroni ML. Review article: gall-bladder motor function in obesity. Aliment Pharmacol Ther 2000; 14 Suppl 2: 48-50
18. Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord 1993; 17: 153-158
19. Dowling RH. Review: pathogenesis of gallstones. Aliment Pharmacol Ther 2000; 14 Suppl 2: 39-47
20. Pazzi P, Scagliarini R, Gamberini S, Pezzoli A. Review article: gall-bladder motor function in diabetes mellitus. Aliment Pharmacol Ther 2000; 14 Suppl 2: 62-65
21. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 1997; 25: 787-790
22. Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JA. Gallstones during octreotide therapy. Metabolism 1992; 41: 22-33
23. Hussaini SH, Murphy GM, Kennedy C, Besser GM, Wass JA, Dowling RH. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994; 107: 1503-1513
24. Qvist N. Review article: gall-bladder motility after intestinal surgery. Aliment Pharmacol Ther 2000; 14 Suppl 2: 35-38
25. Fukagawa T, Katai H, Saka M, Morita S, Sano T, Sasako M. Gallstone formation after gastric cancer surgery. J Gastrointest Surg 2009; 13: 886-889
26. Al-Azzawi HH, Nakeeb A, Saxena R, Maluccio MA, Pitt HA. Cholecystosteatosis: an explanation for increased cholecystectomy rates. J Gastrointest Surg 2007; 11: 835-842; discussion 842-843
27. Schwesinger WH, Diehl AK. Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones. Surg Clin North Am 1996; 76: 493-504
28. Bingener J, Richards ML, Schwesinger WH, Sirinek KR. Laparoscopic cholecystectomy for biliary dyskinesia: correlation of preoperative cholecystokinin cholescintigraphy results with postoperative outcome. Surg Endosc 2004; 18: 802-806
29. Ponsky TA, DeSagun R, Brody F. Surgical therapy for biliary dyskinesia: a meta-analysis and review of the literature. J Laparoendosc Adv Surg Tech A 2005; 15: 439-442
30. Cottam DR, Fisher B, Sridhar V, Atkinson J, Dallal R. The effect of stoma size on weight loss after laparoscopic gastric bypass surgery: results of a blinded randomized controlled trial. Obes Surg 2009; 19: 13-17
31. Choban PS, Flancbaum L. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial. Obes Surg 2002; 12: 540-545
32. Nelson WK, Fatima J, Houghton SG, Thompson GB, Kendrick ML, Mai JL, Kennel KA, Sarr MG. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery 2006; 140: 517-522, discussion 522-523
33. Patiño JF, Quintero GA. Asymptomatic cholelithiasis revisited. World J Surg 1998; 22: 1119-1124
34. Deitel M, Petrov I. Incidence of symptomatic gallstones after bariatric operations. Surg Gynecol Obstet 1987; 164: 549-552
35. Myers JA, Fischer GA, Sarker S, Shayani V. Gallbladder disease in patients undergoing laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2005; 1: 561-563
36. Mason EE, Renquist KE. Gallbladder management in obesity surgery. Obes Surg 2002; 12: 222-229
37. Fobi M, Lee H, Igwe D, Felahy B, James E, Stanczyk M, Fobi N. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 2002; 12: 350-353
38. Hamad GG, Ikramuddin S, Gourash WF, Schauer PR. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg 2003; 13: 76-81
39. Papasavas PK, Gagné DJ, Ceppa FA, Caushaj PF. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 41-46; discussion 46-47
40. Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg 1985; 149: 551-557
41. Guadalajara H, Sanz Baro R, Pascual I, Blesa I, Rotundo GS, López JM, Corripio R, Vesperinas G, Sancho LG, Montes JA. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass? Obes Surg 2006; 16: 883-885
42. Seinige UL, Sataloff DM, Lieber CP, DellaCroce JM, Sorouri ES. Gallbladder Disease in the Morbidly Obese Patient. Obes Surg 1991; 1: 51-56
43. Nougou A, Suter M. Almost routine prophylactic cholecystectomy during laparoscopic gastric bypass is safe. Obes Surg 2008; 18: 535-539
44. Liem RK, Niloff PH. Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 2004; 14: 763-765
45. Villegas L, Schneider B, Provost D, Chang C, Scott D, Sims T, Hill L, Hynan L, Jones D. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg 2004; 14: 206-211
46. Caruana JA, McCabe MN, Smith AD, Camara DS, Mercer MA, Gillespie JA. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary? Surg Obes Relat Dis 2005; 1: 564-567; discussion 567-568
47. Ahmed AR, O'Malley W, Johnson J, Boss T. Cholecystectomy during laparoscopic gastric bypass has no effect on duration of hospital stay. Obes Surg 2007; 17: 1075-1079
48. Escalona A, Boza C, Muñoz R, Pérez G, Rayo S, Crovari F, Ibáñez L, Guzmán S. Routine preoperative ultrasonography and selective cholecystectomy in laparoscopic Roux-en-Y gastric bypass. Why not? Obes Surg 2008; 18: 47-51
49. Taylor J, Leitman IM, Horowitz M. Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass? Obes Surg 2006; 16: 759-761
50. Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc 2008; 22: 2450-2454
51. Gallstones and laparoscopic cholecystectomy. NIH Consensus Development Panel on Gallstones and Laparoscopic Cholecystectomy. Surg Endosc 1993; 7: 271-279
52. Society for Surgery of the Alimentary Tract. SSAT patient care guidelines. Treatment of gallstone and gallbladder disease. J Gastrointest Surg 2007; 11: 1222-1224
53. Swartz DE, Felix EL. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis 2005; 1: 555-560
54. Fuller W, Rasmussen JJ, Ghosh J, Ali MR. Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg 2007; 17: 747-751
55. Ellner SJ, Myers TT, Piorkowski JR, Mavanur AA, Barba CA. Routine cholecystectomy is not mandatory during morbid obesity surgery. Surg Obes Relat Dis 2007; 3: 456-460
56. Portenier DD, Grant JP, Blackwood HS, Pryor A, McMahon RL, DeMaria E. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis 2007; 3: 476-479
57. Patel KR, White SC, Tejirian T, Han SH, Russell D, Vira D, Liao L, Patel KB, Gracia C, Haigh P, Dutson E, Mehran A. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surg 2006; 72: 857-861
58. Patel JA, Patel NA, Piper GL, Smith DE 3rd, Malhotra G, Colella JJ. Perioperative management of cholelithiasis in patients presenting for laparoscopic Roux-en-Y gastric bypass: have we reached a consensus? Am Surg 2009; 75: 470-476; discussion 476
59. McSherry CK, Ferstenberg H, Calhoun WF, Lahman E, Virshup M. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202: 59-63
60. Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg 1993; 165: 399-404
61. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20: 1-19
62. Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MA, Linner JH, MacDonald KG, MacGregor AM, Martin LF, Oram-Smith JC. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995; 169: 91-96; discussion 96-97
63. Wudel LJ Jr, Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 2002; 102: 50-56
64. Uy MC, Talingdan-Te MC, Espinosa WZ, Daez ML, Ong JP. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg 2008; 18: 1532-1538
65. Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg 2003; 238: 697-702